Page 17 of 32 · 745 questions tagged clinical-trials.
Concretely: STEP 4 · semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
Stated plainly: STEP 3 · semaglutide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I want to know whether this is a real physical effect or…
Conditions: SURMOUNT-1 · injection-site erythema · 15 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading…
What I have: a GLP-1 receptor agonist · SELECT. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to know…
The specifics, since they change the answer: SURMOUNT-5 · headache · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is…
I have read the prescribing information and it addresses the adjacent case but not this one. I can parse the result. I am less sure what it licenses me to conclude. I…
Details up front: orforglipron · tirzepatide. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
Stated plainly: dulaglutide · 4 °C. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
Conditions: SURPASS-3 · dizziness · 15 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The case in front of me: survodutide · 30 °C. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I have: FLOW · headache. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being invited…
The specifics, since they change the answer: SURMOUNT-1 · 5 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
What I have: eight weeks · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would…
Concretely: 12.5 mg · liraglutide. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan…
The obesity pipeline is currently full of phase 2 results being quoted as though they were established magnitudes. Retatrutide at -24.2% over 48 weeks is the…
Setup, so nobody has to ask: PIONEER-4 · vomiting · 7 mg. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Setup, so nobody has to ask: ESSENCE · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the…
What I am working with: liraglutide · semaglutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the arguments for each…
Setup, so nobody has to ask: SURPASS-3 · injection-site erythema · 10 mg. I have read the primary source rather than the summary, which has left me with more…
Conditions: nausea · semaglutide · SUSTAIN-6. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
What I am working with: STEP 8 · semaglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Stated plainly: orforglipron · ATTAIN-1. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody knows, I would rather hear…
My background is chemistry rather than physiology, which may explain where I am stuck. This has the shape of a fact but I cannot find its origin. What I found instead…